Bellicum Pharmaceuticals (NASDAQ: BLCM) has been in continuous long-term downtrend since IPO. Stock price has been showing signs of a bottom (starting Aug 2019 to current) and with very successful … [Read more...] about BLCM #VolatilityWatch
Perceptive Advisors
Foamix Pharmaceuticals: A dermatology play with more than 100% upside potential
Foamix Pharmaceuticals (NASDAQ: FOMX) shares have been on a free fall for the past six months, declining by more than 30 percent to $2.3. The clinical-stage company which develops and commercializes … [Read more...] about Foamix Pharmaceuticals: A dermatology play with more than 100% upside potential
ADMA Enters Into $72.5 Million Loan Facility With Perceptive Advisors
Today ADMA Biologics (Nasdaq: ADMA) announced that they entered into a senior secured loan term facility with Perceptive Advisors for up to $72.5 million under 2 funding tranches. Let's get clarify … [Read more...] about ADMA Enters Into $72.5 Million Loan Facility With Perceptive Advisors
English
Arabic
Chinese (Simplified)
Dutch
French
German
Italian
Japanese
Portuguese
Russian
Spanish
You must be logged in to post a comment.